Hatem Ouf-Abou
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation.
Journal: Journal of cancer research and clinical oncology
Published: November 27, 2020
High Serine-arginine Protein Kinase 1 Expression with PTEN Loss Defines Aggressive Phenotype of Prostate Cancer Associated with Lethal Outcome and Decreased Overall Survival.
Journal: European urology open science
Published: November 09, 2020
Molecular characterization of prostate cancer in Middle Eastern population highlights differences with Western populations with prognostic implication.
Journal: Journal of cancer research and clinical oncology
Published: January 29, 2020
Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer.
Journal: Journal of cancer research and clinical oncology
Published: February 03, 2019
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance.
Journal: Prostate cancer and prostatic diseases
Published: June 14, 2018
Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer.
Journal: Journal of cancer research and clinical oncology
Published: December 30, 2017
Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: November 11, 2015
ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: November 02, 2015
ERG expression in prostate cancer: biological relevance and clinical implication.
Journal: Journal of cancer research and clinical oncology
Published: July 03, 2015
microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients.
Journal: Molecular biology reports
Published: June 15, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026